V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230002261 | 230004709 | 1.58 | 57.8 | Neo-adjuvant (N) | 2016-07-13 | 2016-07-22 | Olaparib | 02 | N | OLAPARIB | 101114523 |
| 230002263 | 230004711 | null | null | null | 2017-05-11 | 2017-06-03 | Carboplatin + Doxorubicin | 02 | null | PEMBROLIZUMAB | 101358969 |
| 230002267 | 230004715 | null | null | null | 2019-05-04 | 2021-08-04 | Cisplatin | 02 | null | DOXORUBICIN | 100945653 |
| 230002268 | 230004716 | null | null | null | null | 2019-09-04 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101222694 |
| 230002269 | 230004717 | 1.6 | 80 | Palliative (P) | 2016-02-04 | 2016-02-09 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100652381 |
| 230002271 | 230004718 | 1.71 | 78.2 | null | null | 2018-05-14 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101413735 |
| 230002273 | 230004720 | null | null | Neo-adjuvant (N) | 2018-07-24 | 2018-08-24 | Bevacizumab+Carbo+Pacliaxel | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100647401 |
| 230002274 | 230004721 | 1.58 | 86.1 | null | null | 2019-07-20 | Niraparib | 02 | null | NIRAPARIB | 100560810 |
| 230002276 | 230004723 | 1.62 | 55.6 | null | 2017-09-01 | 2017-09-07 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101517083 |
| 230002277 | 230004724 | 1.6 | 83.85 | Palliative (P) | 2019-02-25 | 2019-03-03 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101787983 |
| 230002279 | 230004726 | 1.63 | 66.4 | null | 2014-05-16 | 2016-03-01 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101544684 |
| 230002280 | 230004727 | null | null | null | null | 2018-09-05 | Bevacizumab | 02 | null | BEVACIZUMAB | 100493840 |
| 230002281 | 230004728 | 1.57 | 76 | null | 2019-07-30 | 2019-08-18 | null | null | null | NIVOLUMAB | 100728949 |
| 230002282 | 230004729 | 1.56 | 92.6 | null | 2021-09-05 | 2021-10-04 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 100297974 |
| 230002283 | 230004730 | 1.58 | 66 | null | 2018-08-13 | 2018-08-25 | ICON9 TRIAL | 02 | null | FLUOROURACIL + OXALIPLATIN | 100756266 |
| 230002284 | 230004731 | 1.55 | 101 | null | 2019-07-19 | 2019-07-29 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100866680 |
| 230002286 | 230004733 | 1.57 | 59.2 | null | 2019-02-12 | 2019-04-16 | null | 99 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100750655 |
| 230002287 | 230004734 | 1.64 | 45.2 | Palliative (P) | 2019-07-01 | 2019-07-04 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 100304969 |
| 230002289 | 230004736 | 1.62 | null | Neo-adjuvant (N) | 2021-01-27 | 2021-05-09 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101365173 |
| 230002290 | 230004737 | 1.63 | 93.9 | Palliative (P) | 2019-12-15 | 2019-12-19 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101378010 |
| 230002291 | 230004738 | 1.61 | 86 | null | 2018-06-14 | 2018-06-18 | Bevacizumab | 02 | null | BEVACIZUMAB | 101038850 |
| 230002292 | 230004739 | 1.67 | 78.7 | Adjuvant (A) | 2019-09-06 | 2019-11-27 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100400954 |
| 230002293 | 230004740 | 1.55 | 58 | null | null | 2019-07-15 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 100965355 |
| 230002296 | 230004743 | 1.52 | 62.6 | null | 2016-02-28 | 2017-01-21 | null | null | null | BEVACIZUMAB | 100130750 |
| 230002297 | 230004744 | 1.53 | 83.85 | null | 2021-01-06 | 2021-01-11 | Olaparib | 02 | null | OLAPARIB | 100462192 |
| 230002298 | 230004745 | 1.61 | 51.2 | Palliative (P) | 2018-01-24 | 2018-01-27 | null | null | N | LIPOSOMAL DOXORUBICIN | 101543524 |
| 230002299 | 230004746 | 1.5 | 77 | 03 | 2020-10-17 | 2020-10-29 | Liposomal Doxorubicin 40mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 101089932 |
| 230002302 | 230004749 | 1.58 | 76.3 | null | 2019-01-19 | 2019-01-29 | Niraparib | 02 | null | NIRAPARIB | 101803124 |
| 230002303 | 230004750 | 1.62 | 59 | null | 2017-11-20 | 2019-05-05 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100434956 |
| 230002304 | 230004751 | 1.68 | 59 | null | 2018-11-21 | 2019-07-01 | null | null | null | HYDROXYCARBAMIDE | 101702479 |
| 230002305 | 230004752 | 1.67 | 55.7 | null | 2017-11-05 | 2017-12-01 | null | null | null | LIPOSOMAL DOXORUBICIN | 100971822 |
| 230002306 | 230004753 | 1.61 | 116.2 | null | 2018-10-18 | 2018-11-09 | Olaparib | 02 | null | OLAPARIB | 100902029 |
| 230002309 | 230004756 | 1.65 | 69.8 | null | 2020-06-17 | 2020-06-26 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101810486 |
| 230002311 | 230004758 | 1.54 | 69.5 | null | 2021-06-12 | 2021-07-04 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101043389 |
| 230002312 | 230004759 | null | null | null | 2020-11-22 | 2020-12-08 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100449984 |
| 230002315 | 230004762 | 1.6 | 95.3 | Palliative (P) | 2019-10-15 | 2020-12-31 | Cisplatin | 02 | N | TRIAL UNSPECIFIED | 100647048 |
| 230002316 | 230004763 | null | null | null | 2019-09-04 | 2019-09-04 | null | null | null | OLAPARIB | 100958682 |
| 230002317 | 230004764 | 1.65 | 70 | null | null | 2019-06-20 | PEMBROLIZUMAB | 02 | null | TRIAL UNSPECIFIED | 100016451 |
| 230002318 | 230004765 | null | null | Palliative (P) | 2018-12-22 | 2018-12-30 | PACLITAXEL | 02 | N | PACLITAXEL | 100267737 |
| 230002320 | 230004767 | 1.66 | 77.85 | null | 2019-06-30 | 2019-07-09 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100190247 |
| 230002321 | 230004768 | 1.59 | 96 | null | 2019-10-26 | 2020-02-21 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100046257 |
| 230002322 | 230004769 | 1.63 | 63.9 | null | 2016-02-07 | 2016-02-10 | Olaparib | 02 | null | OLAPARIB | 100733512 |
| 230002323 | 230004770 | 1.66 | 88.2 | Neo-adjuvant (N) | 2020-03-26 | 2020-04-03 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100835548 |
| 230002325 | 230004771 | null | null | Neo-adjuvant (N) | null | 2020-04-10 | CARBOPLATIN | 02 | Y | CARBOPLATIN | 101826407 |
| 230002327 | 230004773 | null | null | Neo-adjuvant (N) | null | 2017-03-04 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100739585 |
| 230002328 | 230004774 | 1.65 | 91.7 | Curative (C) | 2014-03-02 | 2018-05-30 | Trial Unspecified | 02 | N | PEMBROLIZUMAB | 101496241 |
| 230002331 | 230004777 | 1.65 | 65.5 | null | null | 2016-10-05 | null | null | null | OLAPARIB | 101729418 |
| 230002332 | 230004778 | 1.72 | 71.3 | null | null | 2019-08-20 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100218936 |
| 230002334 | 230004780 | 1.61 | 58 | null | null | 2019-03-31 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100612079 |
| 230002335 | 230004781 | 1.76 | 63.2 | null | 2016-10-16 | 2016-11-01 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101572000 |